Yanjun Zhang

Bio Island
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Journal: NPJ vaccines

Published: July 10, 2025

An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Journal: NPJ vaccines

Published: February 08, 2025

Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.

Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.

Journal: Nature immunology

Published: June 04, 2024

Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model.

Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model.

Journal: Virologica Sinica

Published: November 05, 2023

Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants.

Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants.

Journal: Nature communications

Published: September 06, 2023

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.

Journal: Cell reports

Published: June 24, 2023

Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models.

Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 25, 2023

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 18, 2023

SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril.

SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril.

Journal: Antiviral research

Published: November 13, 2022

Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes.

Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes.

Journal: Life science alliance

Published: November 02, 2022

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants.

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants.

Journal: Emerging microbes & infections

Published: October 26, 2022

SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope.

SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope.

Journal: Nature microbiology

Published: February 28, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026